Dr. Stephen Gregory Hipskind MD, PhD

Dr. Hipskind is a nationally recognized expert in using SPECT brain imaging to evaluate traumatic and toxic brain injuries. He will be presenting original research on a recently-published clinical trial that suggests that LLLT can be used to effectively treat chronic TBI. Dr. Hipskind will also offer insights into the similarities and differences of SPECT brain imaging between chronic TBI patients treated with LLLT and patients treated with HBOT.